Department of Epidemiology, University Medical Center Groningen, University of Groningen, Groningen 9700 RB, The Netherlands.
J Clin Endocrinol Metab. 2013 Aug;98(8):E1352-9. doi: 10.1210/jc.2013-1680. Epub 2013 May 20.
High-density lipoproteins (HDLs) may directly stimulate β-cell function and glucose metabolism. We determined the relationships of fasting high-density lipoprotein cholesterol (HDL-C), plasma apolipoprotein (apo) A-I and apoA-II, and HDL-C-to-apoA-I and HDL-C-to-apoA-II ratios, as estimates of HDL particle composition, with incident type 2 diabetes mellitus.
A prospective study was carried out in the Prevention of Renal and Vascular End-Stage Disease (PREVEND) cohort after exclusion of subjects with diabetes at baseline (n = 6820; age, 28-75 years). The association of HDL-related variables with incident type 2 diabetes was determined by multivariate logistic regression analyses.
After a median follow-up of 7.7 years, 394 incident cases of type 2 diabetes mellitus were ascertained (5.8%). After adjustment for age, sex, family history of diabetes, body mass index, hypertension, alcohol, and smoking, odd ratios (ORs) for diabetes were 0.55 (95% confidence interval [CI], 0.47-0.64; P < .001), 0.81 (0.71-0.93; P = .002), 0.02 (0.01-0.06; P < .001), and 0.03 (0.01-0.060; P < .001) per 1-SD increase in HDL-C and apoA-I and in the HDL-C-to-apoA-I and the HDL-C-to-apoA-II ratios, respectively. In contrast, apoA-II was not related to incident diabetes (OR = 1.02; 95% CI, 0.90-1.16; P=0.71). The relationships of HDL-C and the ratios of HDL-C to apoA-I and HDL-C to apoA-II remained significant after further adjustment for baseline glucose and triglycerides (OR(HDL) = 0.74 [95% CI, 0.61-0.88], OR(HDL/APO A-I) = 0.14 [0.04-0.44], and OR(HDL/APOA-II) = 0.12 [0.04-0.36]; all P ≤ .001).
Higher HDL-C, as well as higher HDL-C-to-apoA-I and HDL-C-to-apoA-II ratios are strongly and independently related to a lower risk of future type 2 diabetes.
高密度脂蛋白(HDL)可能直接刺激β细胞功能和葡萄糖代谢。我们确定了空腹高密度脂蛋白胆固醇(HDL-C)、血浆载脂蛋白(apo)A-I 和 apoA-II 以及 HDL-C 与 apoA-I 和 HDL-C 与 apoA-II 的比值作为 HDL 颗粒组成的估计值,与 2 型糖尿病的发生之间的关系。
在排除基线时患有糖尿病的患者(n = 6820;年龄 28-75 岁)后,在预防肾脏和血管终末期疾病(PREVEND)队列中进行了一项前瞻性研究。通过多变量逻辑回归分析确定与 HDL 相关的变量与 2 型糖尿病发生之间的关系。
中位随访 7.7 年后,确定了 394 例 2 型糖尿病病例(5.8%)。在调整年龄、性别、糖尿病家族史、体重指数、高血压、酒精和吸烟后,HDL-C 每增加 1-SD,糖尿病的比值比(OR)为 0.55(95%置信区间 [CI],0.47-0.64;P <.001),0.81(0.71-0.93;P =.002),0.02(0.01-0.06;P <.001)和 0.03(0.01-0.060;P <.001),apoA-I 和 HDL-C 与 apoA-I 的比值以及 HDL-C 与 apoA-II 的比值。相比之下,apoA-II 与发生糖尿病无关(OR = 1.02;95%CI,0.90-1.16;P=0.71)。在进一步调整基线血糖和甘油三酯后,HDL-C 与 HDL-C 与 apoA-I 和 HDL-C 与 apoA-II 的比值的关系仍然显著(OR(HDL)= 0.74 [95%CI,0.61-0.88],OR(HDL/APOA-I)= 0.14 [0.04-0.44],OR(HDL/APOA-II)= 0.12 [0.04-0.36];所有 P ≤.001)。
较高的 HDL-C 以及较高的 HDL-C 与 apoA-I 和 HDL-C 与 apoA-II 的比值与未来 2 型糖尿病的风险降低密切相关。